CYP2D6-related oxidation polymorphism in Italy
- 30 April 1994
- journal article
- research article
- Published by Elsevier in Pharmacological Research
- Vol. 29 (3) , 281-289
- https://doi.org/10.1016/1043-6618(94)80051-0
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Debrisoquine oxidation in an Italian population: A study in healthy subjects and in schizophrenic patientsPharmacological Research, 1992
- Molecular genetics of the debrisoquin-sparteine polymorphismClinical Pharmacology & Therapeutics, 1991
- Debrisoquine oxidation polymorphism in a Tasmanian populationEuropean Journal of Clinical Pharmacology, 1991
- Determination of dextromethorphan metabolizer phenotype in healthy volunteersEuropean Journal of Clinical Pharmacology, 1989
- Characterization of the common genetic defect in humans deficient in debrisoquine metabolismNature, 1988
- Genetic variation in the human hepatic cytochrome P-450 systemEuropean Journal of Clinical Pharmacology, 1987
- Polymorphic dextromethorphan metabolism: Co-segregation of oxidative O-demethylation with debrisoquin hydroxylationClinical Pharmacology & Therapeutics, 1985
- DEXTROMETHORPHANAS A SAFE PROBE FOR DEBRISOQUINE HYDROXYLATION POLYMORPHISMThe Lancet, 1984
- Defective N-oxidation of sparteine in man: A new pharmacogenetic defectEuropean Journal of Clinical Pharmacology, 1979
- POLYMORPHIC HYDROXYLATION OF DEBRISOQUINE IN MANThe Lancet, 1977